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In Brief
PI(3)P, the product of VPS34, regulates
canonical autophagy; however,
mammalian cells can produce
autophagosomes through enigmatic
noncanonical VPS34-independent
pathways. Vicinanza et al. show that PI(5)
P can regulate autophagy, even in cells
where VPS34 is compromised and acts
via PI(3)P effectors. This provides a
mechanistic explanation for forms of
noncanonical autophagy.
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Phosphatidylinositol 3-phosphate (PI(3)P), the prod-
uct of class III PI3K VPS34, recruits specific autopha-
gic effectors, like WIPI2, during the initial steps of
autophagosome biogenesis and thereby regulates
canonical autophagy. However, mammalian cells
can produce autophagosomes through enigmatic
noncanonical VPS34-independent pathways. Here
we show that PI(5)P can regulate autophagy via
PI(3)P effectors and thereby identify a mechanistic
explanation for forms of noncanonical autophagy.
PI(5)P synthesis by the phosphatidylinositol 5-kinase
PIKfyve was required for autophagosome biogen-
esis, and it increased levels of PI(5)P, stimulated
autophagy, and reduced the levels of autophagic
substrates. Inactivation of VPS34 impaired recruit-
ment of WIPI2 and DFCP1 to autophagic precursors,
reduced ATG5-ATG12 conjugation, and compro-
mised autophagosome formation. However, these
phenotypes were rescued by PI(5)P in VPS34-inacti-
vated cells. These findings provide a mechanistic
framework for alternative VPS34-independent auto-
phagy-initiating pathways, like glucose starvation,
and unravel a cytoplasmic function for PI(5)P, which
previously has been linked predominantly to nuclear
roles.
INTRODUCTION
Macroautophagy (henceforth autophagy) is a cellular process
that delivers damaged organelles, invasive bacteria, and long-
lived or aggregate-prone proteins to lysosomes for degradation
(Boya et al., 2013). These substrates are engulfed alongwith bulk
cytoplasm by double-membraned, cup-shaped phagophores,
which form autophagosomes after their edges extend and
fuse. After autophagosome-lysosome fusion, the resulting
degradation products are recycled back to the cytosol and are
reused to enhance cell survival during nutrient deprivation. Auto-
phagy impacts the pathogenesis of diverse diseases, includingMoneurodegenerative conditions, cancers, and infectious diseases
(Nixon, 2013).
Many proteins (ATGs) regulate themembrane remodelling and
trafficking events in autophagy, but comparatively little is known
about the roles of lipids and their metabolizing enzymes in this
process (Nakatogawa et al., 2009). Phosphoinositides (PIs) are
low-abundance lipids that are interconverted by highly regulated
sets of PI kinases and phosphatases. The interconvertibility of
PIs enables rapid local changes in the identity of intracellular
compartments to dynamically recruit effector proteins to specific
membranes at the right time. The class III phosphatidylinositol
3-kinase (also known as VPS34) and its product phosphati-
dylinositol 3-phosphate (PI(3)P) are critical for autophagosome
formation (Boya et al., 2013; Nakatogawa et al., 2009). Local in-
creases of PI(3)P recruits proteins associated with autophagy
initiation, such as DFCP1 (double FYVE-containing protein 1)
and the WIPI proteins (WD-repeat protein interacting with PI),
of which WIPI2 has been characterized as an effector of auto-
phagy (Polson et al., 2010).
While autophagy has been classically considered to be PI(3)P-
dependent, noncanonical VPS34-independent autophagy has
been reported (Codogno et al., 2012; Plowey et al., 2008; Scar-
latti et al., 2008; Zhu et al., 2007), as autophagosomes are seen in
T lymphocytes and sensory neurons from Vps34/ mice (Zhou
et al., 2010) and in glucose-starved cells treated with the VPS34
inhibitor Wortmannin (Wm) (McAlpine et al., 2013). However, it is
unclear whether these phenomenamay be explicable by VPS34-
independent source(s) of PI(3)P (Devereaux et al., 2013) or by
other PIs.
PI(5)P remains the most enigmatic of the PIs due to its low
abundance (Shisheva, 2013). The pathways regulated by PI(5)P
in mammalian cells and its effectors/binding proteins are still
poorly understood. So far these include chromatin organization
in the nuclei, bacteria invasion, and cytoskeletal remodelling
(Shisheva, 2013). Here, we describe a role for PI(5)P as a regu-
lator of autophagosome biogenesis that can also regulate auto-
phagy when VPS34 is inhibited.
RESULTS
PI(5)P Regulates Autophagosome Biogenesis
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versus a loading control (e.g., tubulin), or by scoring the number
of LC3-positive vesicles, since LC3-II is specifically targeted
to autophagosomal membranes (Kabeya et al., 2000). In the
same way that PI(3)P alone is sufficient to stimulate autophagy
in mammalian cells (Petiot et al., 2000), we found that addition
of exogenous PI(5)P di-C16 significantly increased LC3-II levels
and LC3-positive autophagic vesicle numbers (Figures 1A–1D).
While LC3-II levels correlate with autophagosome numbers,
these can increase due to enhanced formation or decreased
degradation (Rubinsztein et al., 2009). Consistent with a role in
autophagosome synthesis, PI(5)P increased LC3-II levels, in an
apparently dose-dependent manner, when we blocked LC3-II
clearance by inhibiting autophagosome-lysosome fusion using
Bafilomycin A1 (BAF) (Figures 1A and 1B and Figures S1A and
S1B available online), and resulted in increased numbers of
GFP-LC3 puncta (autophagosomes) in both nutrient-replete me-
dia andHank’s balanced salt solution (HBSS) (amino-acid/serum
starvation and 1 g/l D-glucose, compared to 4.5 g/l in Dulbecco’s
modified Eagle’s medium [DMEM]) (Figures 1C and 1D). The
effects of PI(3)P (a positive control) were stronger at 0.1 mM
compared to PI(5)P, while the effects of PI(5)P were more notice-
able at 1 and 10 mM (Figures S1A and S1B). PI and PI(4)P did
not obviously stimulate autophagy, and PI(4)P loading of cells
treated with BAF suggested possible inhibition of autophagy
(Figure S1C). PI(5)P loading in cells stably expressing mRFP-
GFP tandem fluorescent-tagged LC3 (see Supplemental Exper-
imental Procedures) increased the numbers of autophagosomes
and autolysosomes (Figures 1E and S1D). Furthermore, addition
of PI(5)P increased the conjugation of ATG5 with ATG12 (Figures
1F and 1G), a critical event in phagophore biogenesis that ap-
pears to be regulated by PI(3)P (Ravikumar et al., 2008).
Exogenous PI(5)P was delivered to autophagic structures, as
we observed fluorescent BODIPY-labeled PI(5)P on RFP-LC3
puncta (Figure S1E). BODIPY-labeled PI(5)P loading of living cells
increased the number of RFP-LC3 dots dose dependently (Fig-
ure S1E). One difficulty in studying the intracellular localization
of endogenous PI(5)P is the uncertain specificity of PI(5)P bio-
probes. While the plant homeodomain (PHD) of ING2 (Bua et al.,
2013; Gozani et al., 2003) and the pleckstrin homology (PH)Figure 1. PI(5)P Regulates Autophagosome Biogenesis
(A and B) Western blot analysis of LC3-II and tubulin levels and quantification of LC
PI(5)P di-C16 at indicated concentrations for 1 hr, in the absence and presence o
faint compared with LC3-II in HeLa cells under the protein extraction conditions w
relate LC3-II to tubulin (mean ± SEM).
(C and D) HeLa cells stably expressing GFP-LC3 were treated as in (A) and then le
analyzed on a Cellomics ArrayScan system. Quantification of numbers of GFP-L
(E) HeLa cells stably expressing GFP-mRFP-LC3 were treated as in (A) and analyz
vesicles (AV) or autolysosomes (AL) per cell in the different conditions is shown i
(F and G) Western blot analysis of free ATG12 and ATG5-ATG12 complex levels
loaded with exogenous lipids. We quantified the ratio of ATG5-ATG12 versus f
Imaging System to assess ATG5-ATG12 conjugation efficiency (mean ± SEM).
(H) HeLa cells transfected with GFP-PHD3X or GFP-PHD3X Znmut and RFP-LC3
then fixed and imaged on a confocal microscope. Empty arrowheads indicate P
and PHD3X-ATG16-positive structures. Bar, 10 mm.
(I) HeLa cells transfected with GFP-PHD3X and RFP-LC3 for 16 hr were left in HB
visualization was performed in Volocity 6.3 software using isosurface rendering of
vesicles positive for green and red do not look yellow but have green and red on th
1.13 mm. See also Figure S1.
Modomain of Dok proteins (Guittard et al., 2009, 2010) show strong
preference for PI(5)P andhave been used for intracellular localiza-
tion and manipulation of PI(5)P (Viaud et al., 2014a), we cannot
exclude that they do not bind other lipids to some extent. With
this caveat in mind, we detected GFP-tagged PHD3X (three tan-
dem repeats of PHD of ING2) (Bua et al., 2013; Gozani et al.,
2003; Guittard et al., 2010) localization at the nucleus and plasma
membrane (aspreviouslydescribed)andondiscretepuncta, 25%
of which were RFP-LC3 positive (Figure 1H). When cells were
starved, GFP-PHD3X-positive structures increased from 4–6 to
>12 spots per cell, 50% of which colocalized with RFP-LC3 (Fig-
ure 1H). A PHDmutant defective in PI(5)P binding (PHD3X Znmut)
(Bua et al., 2013) failed to localize on discrete structures (Fig-
ure 1H). Superresolution structured illumination microscopy
(SR-SIM) confirmed the confocal localization of PHD3X on LC3-
positive vesicles/autophagosomes (Figure 1I; Movie S1).
Overexpression of GFP-PHD3X, which sequesters intra-
cellular PI(5)P, dramatically decreased the percentage of cells
with more than 10 LC3 dots (both endogenous LC3 and RFP-
tagged LC3 were assessed), compared to GFP-empty vector
or GFP-PHD3X Znmut (Figures S1F–S1I), an effect mimicked
by overexpression of GFP-PH-Dok-5, an alternative PI(5)P bind-
ing module (Guittard et al., 2010; Figures S1F and S1G). As we
could not exclude that some of the effects of these probes
may be due to binding to other lipids, we next manipulated intra-
cellular PI(5)P levels by targeting enzymes relevant for its biogen-
esis and turnover.
PI(5)P Synthesized by PIKfyve Regulates
Autophagosome Formation
Type III PtdInsP 5-kinase PIKfyve appears to regulate PI(5)P
biosynthesis (Figure 2A; Sbrissa et al., 1999), as reduced PI(5)
P levels are seen in PIKfyve hypomorph and heterozygous
mice and in cells silenced by small interfering RNA (siRNA), over-
expressing a dominant-negative mutant or treated with pharma-
cological inhibitor of the kinase (Ikonomov et al., 2011; Sbrissa
et al., 2002, 2012; Zolov et al., 2012). Low doses (100 nM) of
the PIKfyve inhibitor YM-201636 (Sbrissa et al., 2012) decreased
LC3-II levels (Figures 2B, 2C, and S2A), the number of ATG16L13-II/tubulin ratio in HeLa cells treated with carrier alone, or in combination with
f 400 nM BAF (treated in combination with lipids). Note that LC3-I is often very
e used (see Figure S1C). However, this was not a problem because one should
ft in complete media (basal) or starvation media (HBSS) for 2 hr, then fixed and
C3 vesicles per cell in the different conditions is shown in (D) (mean ± SEM).
ed on a Cellomics ArrayScan system. Quantification of numbers of autophagic
n the graph (mean ± SEM).
with anti-HA antibody in HeLa cells transfected with HA-ATG12 and ATG5 and
ree ATG12 by direct infrared fluorescence detection on an Odyssey Infrared
for 16 hr were left in complete media (basal) or starvation media (HBSS) for 1 hr,
HD3X single-labeled structures, while filled arrowheads indicate PHD3X-LC3-
SS for 1 hr, then fixed and imaged on Elyra superresolution microscope. Final
selected cropped regions of the data sets. Note that this rendering means that
e surface. Representative cropped regions from different cells are shown. Bar,
lecular Cell 57, 219–234, January 22, 2015 ª2015 The Authors 221
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(autophagosome precursor) andWIPI-2 vesicles (Figures 2D and
2E), and ATG5-ATG12 conjugation (Figure 2F).
Autophagosomesmay contain PI(5)P from early stages of their
biogenesis, since GFP-PHD3X was associated with mStraw-
berry-ATG16L1 structures (which label phagophores or prepha-
gophore structures) in both nutrient-replete and starved condi-
tions (50% and 70% colocalization, respectively) (Figure S2B).
A 3D analysis of PHD3X-labeled structures assessed by super-
resolution structured illumination microscopy (SR-SIM) revealed
PI(5)P on ATG16L1-positive vesicles in autophagy-stimulating
conditions (amino-acid starvation, HBSS media) (Figure 2G;
Movie S2). Low doses of YM-201636 (100 nM) or PIKfyve
silencing selectively depleted GFP-PHD3X on ATG16L1 vesi-
cles, consistent with a specific reduction of PI(5)P on autophago-
some precursors (Figures S2B and S2C). To further validate the
idea that PI(5)P is present on early autophagic membranes, we
expressed the GFP-PHD3X probe, in cells where phagophores
accumulated and autophagosome completion was impaired by
the overexpression of proteolytic-activity-deficient mutant of
ATG4B (ATG4BC74A), that prevents LC3 lipidation and inhibits
autophagosome formation (Fujita et al., 2008). ATG4BC74A
increased the numbers of ATG16L1 structures labeled with
GFP-PHD3X, in both basal and starvation conditions (Fig-
ure S2D), with some forming large ring-shaped structures.
PIKfyve is also the primary kinase responsible for production
of PI(3,5)P2, a key regulator of early-to-late endosome mem-
brane trafficking (Shisheva, 2013; Figure 2A). Note that higher
concentrations and longer treatment with YM-201636, which in-
hibits PI(3)P conversion to PI(3,5)P2, causing elevation of PI(3)P
(de Lartigue et al., 2009; Zolov et al., 2012), do not reduce auto-
phagosome numbers (Figures 2B, 2C, and S2A), possibly due to
defects in the endosomal/lysosomal compartment that block
autophagosome degradation (Figures 2A, S2A, and S2E).
Consistent with this, a similar block in autophagosome degra-
dation is seen with PIKfyve siRNA knockdown (Figure S2F).
To parse out the effects of impaired autophagosome forma-
tion and degradation, we treated cells with BAF for 2 hr in the
presence of HBSS (an autophagy stimulus), and we found
less autophagosome formation in the PIKfyve knockdown cells
(Figure S2G), consistent with reduced ATG5-ATG12 conjugation
after PIKfyve knockdown (as seen with short-term low-dose
YM-201636 treatment) (Figure S2H). Importantly, the addition
of exogenous PI(5)P di-C16 to cells treated with low concentra-
tions of YM-201636 (Figures 2H and 2I) or treated with PIKfyve
siRNA (Figures S2G and S2H) significantly rescued LC3-II levelsFigure 2. PI(5)P Synthesized by PIKfyve Regulates Autophagosome Fo
(A) Schematic representation of pathways for PI(5)P and PI(3)P synthesis/turnov
(B and C) Western blot analysis of LC3-II and tubulin levels and quantification of LC
of YM-201636 for 2 hr in the presence or absence of BAF (mean ± SEM).
(D and E) HeLa cells transiently transfected with Strawberry-ATG16L1 were
for endogenous WIPI-2. Bar, 10 mm. (E) Quantification of ATG16L1 and WIPI2 s
***p < 0.001, t test).
(F) Western blot analysis of free ATG12 and ATG5-ATG12 complex levels with an
with YM-201636 (100 nM, 2 hr) (mean ± SEM).
(G) HeLa cells transfected with GFP-PHD3X and Strawberry-ATG16L1 for 16 h
microscope. Final visualization was performed as previously described. Bar, 1.1
(H and I) Western blot analysis of LC3-II and tubulin levels and quantification of LC
with exogenous PI(5)P for the last 1 hr in the presence or absence of BAF (mean
Moand ATG5-ATG12 conjugation, arguing that PI(5)P is the rele-
vant signaling molecule in PIKfyve-dependent autophagosome
biogenesis.
Several in vivo studies suggest that PIKfyve may indirectly
control PI(5)P levels by producing PI(3,5)P2, which is then trans-
formed into PI(5)P by 3-phosphatases of the myotubularin fam-
ily (Figure 2A; Oppelt et al., 2013, 2014; Viaud et al., 2014b;
Zolov et al., 2012). If this is the case, then the production of
PI(5)P is likely localized to internal membranes where PI(3,5)
P2 is located. We investigated the localization of PI(3,5)P2 using
the tandem repeats of the N-terminal domain of mucolipin1
(ML1N*2), recently described as a reliable and specific probe
for PI(3,5)P2 (Li et al., 2013). GFP-ML1N*2 associated with
early autophagosomal structures labeled with mStrawberry-
ATG16L1 under nutrient-starvation conditions (80% of ATG16
structures contain GFP-ML1N*2 during starvation versus 20%
in complete media), and this association was sensitive to YM-
201636 treatment (Figure S2I). Consistent with PI(3,5)P2 being
a precursor of PI(5)P, we found that overexpression of myotubu-
larin-related phosphatase 3 (MTMR3), one of the myotubularin
PI 3-phosphatase enzymes previously implicated in PI(5)P pro-
duction along with PIKfyve (Oppelt et al., 2013, 2014; Viaud
et al., 2014b; Zolov et al., 2012), increased numbers of GFP-
PHD3X structures, while its knockdown had the reverse effect
(Figure S2J) during nutrient starvation (HBSS). Various myotu-
bularin family members have been linked to autophagy, mainly
in the regulation of PI3P metabolism (Taguchi-Atarashi et al.,
2010; Vergne et al., 2009; Zou et al., 2012). Thus, myotubularins
other than MTMR3 may also regulate PI(5)P levels during
autophagy induction, like PI(3)P. PI(3,5)P2 localization during
starvation resembles what we found for PI(5)P, and raises the
possibility that PI(3,5)P2 may contribute as a precursor for the
PI(5)P pool required for autophagy (Figure 2A). PI(5)P and its
precursor PI(3,5)P2 localize on autophagosome precursors,
and inhibition of their synthesis results in autophagy inhibition.
Our data provide clear evidence that PI(5)P synthesis occurs
during early stages of autophagosome formation and is modu-
lated by nutrient state.
Kinases that Convert PI(5)P to PI(4,5)P2
Regulate Autophagy
The major route for PI(5)P removal is attributed to type II PI5PK
kinases (phosphatidylinositol 5-phosphate 4-kinases, PI5P4K2s)
(Figure 2A; Clarke et al., 2010; Shisheva, 2013; Viaud et al.,
2014a). Mammalian genomes contain three genes, PI5P4K2A,rmation
er and drugs targeting enzymes involved in these pathways.
3-II/tubulin ratio in HeLa cells treated with DMSO or increasing concentrations
treated with YM-201636 (100 nM, 2 hr) in HBSS, then fixed and stained
tructures per cell, n = 20 cells (mean ± SEM; n = 3 independent experiments;
ti-HA antibody in HeLa cells transfected with HA-ATG12 and ATG5 and treated
r were left in HBSS for 1 hr, then fixed and imaged on Elyra superresolution
3 mm.
3-II/tubulin ratio in cells incubated with YM-201636 (100 nM, 2 hr) and loaded
± SEM). See also Figure S2.
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B, and C, encoding three type II PI(5)P 4-kinase isoforms, alpha
(PI5P4K2a), beta (PI5P4K2b), and gamma (PI5P4K2g), respec-
tively. Silencing of the three PI5P4K2s, which increase cellular
PI(5)P levels (Sarkes and Rameh, 2010; Wilcox and Hinchliffe,
2008), increased autophagosome formation (increased levels
of LC3-II in the presence of BAF) (Figures 3A, 3B, and S3A–
S3E), autophagosome and autolysosome numbers (in cells sta-
bly expressing mRFP-GFP tandem fluorescent-tagged LC3)
(Figures 3C and S3F), and ATG5-ATG12 conjugation (Figure 3D).
PI5P4K2A, B, and C silencing resulted in more obvious localiza-
tion of GFP-PHD3X on autophagosome precursors and mature
autophagosomes (ATG16L1 and RFP-LC3-positive structures)
(Figure S3G). Consistent with the distribution of PI(5)P (Fig-
ure 1H), PI5P4K2a, b, and g localized to different extents on au-
tophagosomes (RFP-LC3 structures, Figure 3E), with PI5P4K2g
showing the most prominent association with autophagosomal
structures. The different PI5P4K2 isoforms appeared to have
different efficacies. While this may be due to different knock-
down efficiencies, we noted that PI5P4K2C, whose knockdown
had the strongest effect, was also most obviously associated
with autophagosomes. Overexpression of active GFP-tagged
PI5P4K2a, b, and g, which attenuate signaling from PI(5)P (by
consuming PI(5)P to produce PI(4,5)P2), impaired autophagy
(Figures 3F and 3G), while a GFP-tagged PI5P4K2g-inactive
mutant did not (Figures 3F and 3G). These data indicate a func-
tion for PI(5)P in the induction of autophagy.
PI5P4K2s Alter the Levels of Autophagy Substrates
PI(5)P loading significantly increased LC3-II levels (in the
absence and presence of BAF) in both human neuroblastoma
(SKNSH) and mouse embryonic fibroblasts (MEFs) (Figures 4A
and 4B). We investigated the effects of PI5P4K2s knockdown
and overexpression on the levels of diverse autophagic sub-
strates, including the ubiquitin-binding adaptor protein p62 and
a mutant form of huntingtin associated with Huntington’s dis-
ease (EGFP-httQ74) (Ravikumar et al., 2002). PI5P4K2s knock-
down decreased the levels of p62 (Figures S3A–S3C) and the
numbers of cells with mutant huntingtin aggregates (Figures
4C and 4D), which correlate with mutant protein levels (Narain
et al., 1999), like other autophagy inducers (Williams et al.,
2008), while PI5P4K2C overexpression had the opposite effect
(Figures 4C–4E). While PI5P4K2C silencing decreased the pro-
portion of cells with EGFP-httQ74 aggregates and the opposite
was seen with PI5P4K2C overexpression, these effects were
only seen in wild-type (WT, Atg5+/+) MEFs, and not in auto-
phagy-deficient cells (Atg5/), suggesting these PI5P4K2C ef-
fects are autophagy dependent (Figures 4F, 4G, S4A, and S4B).Figure 3. PI5P4K2s Localize on Autophagosomes and Regulate Autop
(A and B)Western blot analysis of LC3-II and tubulin levels and quantification of LC
PI5P4K2A, 2B, or 2C siRNA either left untreated or treated with BAF (200 nM, 16
(C) HeLa cells stably expressing GFP-mRFP-LC3 treated as in (A) were analyzed
(D) Western blot analysis of free ATG12 and ATG5-ATG12 complex levels with an
and transfected with HA-ATG12 and ATG5 for the last 16 hr (mean ± SEM).
(E and F) HeLa cells transfected with GFP-PI5P4K2A, 2B, 2C, or catalytic-dead PI5
confocal microscope. Bar, 10 mm.
(G) Quantification of cells (percentage of total) showing more than ten autophagic
graph; n = 200 cells (mean ± SEM). See also Figure S3.
MoPI(5)P Sustains Autophagy in Cells Depleted of PI(3)P
We tested whether PI(5)P could sustain autophagy in cells
depleted of PI(3)P with the VPS34 inhibitor Wm. We validated
the specificity of Wm for VPS34 activity during autophagy induc-
tion by treating VPS34-null MEFs (Figure S5A) and HeLa or GFP-
LC3 HeLa stable cell lines withWm for 2 hr in HBSS (Figures S5B
and S5C). Consistent with previous studies, Wm inhibited ATG5-
ATG12 conjugation, LC3 lipidation, and prevented autophago-
some formation (Blommaart et al., 1997; Ravikumar et al.,
2008; Figures S5A–S5D; Figures 5A–5D). VPS34-null MEFS are
insensitive to Wm compared to their WT counterparts (Fig-
ure S5A), and autophagy inhibition caused by Wm in HBSS-
treated cells was rescued by PI(3)P supplementation (Figures
S5B and S5C). VPS34-null cells did not have obviously
decreased autophagy in HBSS (Figure S5A) like Wm-treated
cells, suggesting that long-term VPS34 depletion may be
compensated for by alternative pathways or by additional de-
fects in autophagosome degradation (Devereaux et al., 2013).
PI(3)P also regulates proteins crucial for sorting to vacuoles or
lysosomes (Schink et al., 2013), and long-term VPS34 inhibition
can impair endocytic trafficking (Petiot et al., 2003; Siddhanta
et al., 1998) and cause vacuolation of late endosomal compart-
ments (Futter et al., 2001) and mistrafficking of cathepsin D
from late endosomes to lysosomes (Row et al., 2001).
To test whether PI(5)P was able to sustain autophagy in cells
depleted of PI(3)P, we used acute Wm treatment and loaded
cells with exogenous PI(5)P di-C16. Under these conditions,
the requirement for the generation of PI(3)P appeared to be abro-
gated, as we detected LC3 lipidation (Figures 5A and 5B),
increased LC3 vesicles under starvation (Figures 5C and S5C),
increased double-membraned autophagosomes by electron
microscopy (Figure S5D), and ATG5-ATG12 conjugation (Fig-
ure 5D), even in the presence of Wm. Similarly, increasing
endogenous PI(5)P levels by PI5P4K2s knockdown resulted in
an increase in LC3-II levels (Figures 5E and 5F), ATG5-ATG12
conjugation (Figures 5G and 5H), and numbers of LC3 vesicles
(Figures 5I and S5E) that were resistant to Wm.
As a genetic alternative to Wm, we performed a short-term
siRNA knockdown of VPS34, which does dramatically impact
autophagy in HBSS (in contrast to longer-term knockdowns or
Cre-mediated gene excision in the MEFs) (Figure S5A). In such
VPS34-siRNA-treated cells, PI(5)P was able to rescue auto-
phagy and ATG5-ATG12 conjugation. (Figure S5F).
We also manipulated PI(5)P and PI(3)P levels by overexpress-
ing MTMR3, which would decrease PI(3)P levels but increase
PI(5)P levels (Figures 2A and S5G). MTMR3 overexpression
(but not MTMR3C413S catalytic mutant overexpression) inhagy
3-II/tubulin ratio in HeLa cells transfected for 5 days with two rounds of control,
hr) (mean ± SEM).
on a Cellomics ArrayScan system as previously described (mean ± SEM).
ti-HA antibody in HeLa cells treated with control, PI5P4K2A, 2B, and 2C siRNA
P4K2C along with RFP-LC3 for 16 hr (E) or 30 hr (F) were fixed and imaged on a
vesicles (RFP-LC3 vesicles) in the different conditions from (F) is shown in the
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GFP-LC3 HeLa cells incubated in HBSS impaired autophago-
some formation (BAF for 4 h), as previously reported (Taguchi-
Atarashi et al., 2010; Figures 5J and 5K). This effect is likely
due to the effects of MTMR3 on PI(3)P catabolism, which would
be expected to blunt the HBSS-induced autophagy-stimulating
levels of this lipid. To measure the effect of MTMR3 overexpres-
sion in a context where the role of PI(3)P can be excluded (Fig-
ure 2A), to allow us to largely focus our attention on the ability
of this enzyme to generate PI(5)P, we treated cells with BAF
and Wm for 4 hr in the presence of HBSS, and we found that
overexpression of WT, but not of catalytic dead MTMR3 (Figures
5J and 5K), could rescue LC3 vesicle numbers in Wm-treated
cells. Conversely, increasing PI(3)P (by loading of exogenous
PI(3)P di-C16) restored LC3 dots in cells depleted of PI(5)P
by overexpression of active PI5P4K2a, b, and g (Figures 5L
and 5M). Thus, our results point toward a common mechanism
of action for PI(3)P and PI(5)P during autophagy.
PI(5)P and PI(3)P Share Common Effectors during
Autophagosome Formation
Since PI(5)P can rescue autophagy in PI(3)P-depleted cells, we
tested if PI(5)P regulates autophagosome formation similarly to
PI(3)P, through the recruitment of theWIPI2 andDFCP1 proteins.
GFP-WIPI2 and DFCP1 puncta, which disappeared in starved
cells treated with Wm, remained when such Wm-treated cells
were preloaded with PI(5)P (Figures 6A and S6A), and the mem-
brane association of GFP-WIPI2 and GFP-DFCP1 was dramati-
cally impaired by Wm, but was Wm-insensitive in PI5P4K2
knockdown cells (Figures 6B–6D and S6B). Thus, WIPI2 and
DFCP1 membrane binding can be preserved by PI(5)P in Wm-
treated cells.
We examined whether WIPI2 proteins bind to PI(5)P using ex-
tracts from cells expressing GFP-tagged WIPI2B and WIPI2D,
which we then precipitated with beads coated with different
PIs (Figures 6E and S6C). WIPI2 proteins were associated
with PI(5)P beads, but not with PI or uncoated beads (Figures
6E and S6C). This association seemed to be specific because
the PI(5)P binding was inhibited when cell extracts were prein-
cubated with PI(5)P-containing but not PS-containing lipo-
somes (Figure 6F). Similar effects also were observed for the
binding of WIPI2B to PI(3)P beads and for the competition of
PI(3)P-containing liposomes with PI(3)P beads (Figures 6E and
6G). WIPI2B protein pull-down by the PI(3)P beads was strongly
affected by preincubation with PI(5)P-containing liposomes
(Figure 6H). Likewise, WIPI2B protein pull-down by the PI(5)P
beads was strongly affected by preincubation with PI(3)P-con-
taining liposomes (Figure 6H). Furthermore, a WIPI2 mutantFigure 4. PI5P4K2A and PI5P4K2C Regulate Accumulation of Mutant H
(A and B) Western blot analysis of LC3-II and tubulin levels and quantification of
combination with PI(5)P di-C16 (10 mM) in the absence and presence of BAF (me
(C) HeLa cells treated with PI5P4K2A or PI5P4K2C siRNA for 5 days or with pCM
httQ74 for the last 48 hr. Percentage of cells with EGFP-positive aggregates is sh
typically have 25% of aggregates and we set the control at 100% to enable com
(D and E) Percentage of cells with EGFP-positive aggregates was scored in HEK2
httQ74 for the last 48 hr (D), or in COS7 and SKNSH cells (E), transfected with P
(F and G) WT (Atg5+/+) or autophagy-deficient cells lacking the key autophagy
PI5P4K2C plasmid (48 hr) together with EGFP-httQ74 for 48 hr. The percentages o
the graph; n = 500 cells (mean ± SEM). Representative confocal images are sho
Mothat was predicted not to bind to PI(3)P (Dooley et al., 2014)
had similarly reduced binding to PI(5)P (Figure 6I). Thus, PI(5)P
binds a PI(3)P effector involved in autophagosome biogene-
sis; we tested if PI(5)P was required for PI(3)P-independent
autophagy.
Autophagy Activation following Glucose Starvation Is
Dependent upon PI(5)P, but Not PI(3)P
Since we found that PI(5)P can sustain autophagy inWm-treated
cells, we considered that PI(5)P may regulate autophagy path-
ways where PI(3)P is dispensable, such as glucose-starvation-
induced autophagy (McAlpine et al., 2013), a hypothesis
strengthened by our observation that HBSS or glucose starva-
tion increase the phosphorylation of PIKfyve at residues where
this enhances its catalytic activity (Er et al., 2013; Hill et al.,
2010; Liu et al., 2013; Figure S7A). Glucose deprivation in
HeLa cells stably expressing GFP-LC3 increased the number
of autophagosomes in DMSO- and Wm-treated cells, but not
when PIKfyve was inhibited by YM-201636 treatment (Figures
7A and 7B). Conversely, both Wm and YM-201636 strongly
affected but did not completely ablate autophagosome forma-
tion under amino-acid/serum starvation (HBSS, Figures 7A and
7B). We confirmed that YM-201636 reduced LC3-II levels in
both glucose-starved MEFs and SKNSH cells, and that this phe-
nomenon was not seen with Wm (Figure 7C). Consistent with a
specific requirement for PI(5)P for autophagy induction during
glucose withdrawal, we observed a significant YM-201636-sen-
sitive increase in the number of ATG16-positive autophago-
somes containing PI(5)P in glucose-depleted cells (Figure 7D).
When PI(5)P was sequestered by GFP-PHD3X overexpression
or removed by overexpression of active PI5P4K2a, b, and g,
the appearance of LC3 dots following glucose starvation was
abolished (Figures 7E, 7F, and S7B). Consistent with the different
effects of Wm treatment under nutrient starvation, we did not
detect an increased number of PI(3)P-containing autophago-
somes (using the GFP-FYVE2X probe or anti-PI(3)P antibodies)
in cells depleted of glucose compared to HBSS media (Figures
S7C and S7D).
Supporting the idea that PI(3,5)P2 contributes to the genera-
tion of PI(5)P during nutrient starvation, we observed increased
colocalization of GFP-ML1N*2 with RFP-LC3 under glucose
and amino-acid/serum starvation (Figure S7E). Indeed, MTMR3
knockdown significantly reduced PI(5)P on autophagosomes
(Figure 7G), inhibited autophagosome formation in glucose-
starved cells (where PI(3)P is dispensable), and this effect could
be reversed by adding back PI(5)P (Figures S7F and S7G).
Collectively, our results argue that PI(5)P generated by PIKfyveuntingtin Exon 1
LC3-II/tubulin ratio in SKNSH and MEFs treated for 2 hr with carrier alone or in
an ± SEM).
V-PI5P4K2C overexpression construct for 48 hr were transfected with EGFP-
own in the graph; n = 500 cells (mean ± SEM). Cells expressing control vector
parison and statistics from independent experiments.
93 cells treated with PI5P4K2C siRNA for 5 days and cotransfected with EGFP-
I5P4K2C plasmid together with EGFP-httQ74 for the last 48 hr.
gene Atg5 (Atg5/) MEFs were treated with PI5P4K2C siRNA (5 days) or
f transfected cells with EGFP-httQ74 aggregates were assessed and shown in
wn in (G). See also Figures S3 and S4.
lecular Cell 57, 219–234, January 22, 2015 ª2015 The Authors 227
(legend on next page)
228 Molecular Cell 57, 219–234, January 22, 2015 ª2015 The Authors
and MTMR3 is the relevant lipid species for autophagosome
generation during glucose starvation. Resveratrol induces auto-
phagy in noncanonical manner, independent of Beclin1 and
partially resistant to Wm (Mauthe et al., 2011). The autophagy
stimulation of resveratrol was impaired upon PI(5)P depletion
due to overexpression of PI5P4K2a, b, and g (but not the
catalytic-dead mutant of PI5P4K2g or GFP-empty vector)
(Figure S7H).
When we labeled cells in basal, HBSS, or glucose starvation
for PI(3)P (with an antibody) and for PI(5)P (with GFP-PHD3X),
it was notable that the glucose-starved cells had fewer PI(3)P-
and more PI(5)P-containing ATG16L1 structures, some of which
appeared devoid of PI(3)P (Figure 7H), consistent with a domi-
nant role for PI(5)P during glucose starvation. Our findings
suggest that both PI(5)P and PI(3)P are important regulators of
autophagy induced by HBSS. However, PI(5)P synthesis, but
not PI(3)P synthesis, is required for autophagy induction by
glucose withdrawal.
DISCUSSION
The present work identifies a role for PI(5)P as a regulator of au-
tophagosome biogenesis. PI(5)P synthesis is required for auto-
phagosome formation and this effect is similar to PI(3)P, as
both lipids regulate recruitment of theWIPI2 andDFCP1 proteins
and ATG5-ATG12 conjugation. PI(5)P and kinases acting on PI(5)
P (particularly PI5P4K2g) are associated with autophagosomes
and autophagosome precursors, suggesting that local alter-
ations in the levels of this lipid are important for regulating auto-
phagy. While we cannot exclude that alterations in PI(5)P may
impact autophagosome biogenesis through its metabolites, the
observations that PI(5)P binds to WIPI2, impacts PI(3)P-related
phenotypes like ATG5-ATG12 conjugation, and can rescue auto-
phagy in Wm-treated HBSS-starved cells strongly argue that it
can serve as an alternative to PI(3)P. It is worth bearing in mind
that PI(5)P’s presence in cells is 100 times lower than those
of the most abundant Pis, PI(4,5)P2 and PI(4)P (Sarkes and Ra-
meh, 2010). The major source of PI(4,5)P2, which we previously
have shown to be a positive regulator of autophagy (MoreauFigure 5. PI(5)P Triggers Autophagy in the Absence of VPS34 Activatio
(A and B) Western blot analysis of LC3-II and tubulin levels and quantification of L
with 10 mM PI(5)P for 1 hr (in the presence of Wm and BAF) (mean ± SEM).
(C) Quantification of numbers of GFP-LC3 vesicles in HeLa cells stably express
complete media (Basal) for 2 hr (in the presence of Wm) (mean ± SEM).
(D) HeLa cells transfected with HA-ATG12 and ATG5 treated with 200 nMWmas i
ATG12 and the ATG5-ATG12 complex (mean ± SEM). ATG5-ATG12 conjugation
ATG12 antibody (bottom).
(E and F) Western blot analysis of LC3-II and tubulin levels and quantification of LC
siRNA and treated with Wm (200 nM, 2 hr in the presence of BAF) (mean ± SEM
(G and H) Western blot analysis of free ATG12 and ATG5-ATG12 complex levels w
siRNA, transfected with HA-ATG12 and ATG5 for last 16 hr and treated with Wm
(I) HeLa cells stably expressing GFP-LC3 treated with control, PI5P4K2A, 2B, an
shifted in HBSS media for 2 hr (in the presence of Wm) (mean ± SEM).
(J and K) HeLa cells stably expressing GFP-LC3 were transfected for 30 hr with m
for 4 hr in HBSS in the presence of BAF and in the presence or absence of Wm
microscope. Asterisks indicate transfected cells. Quantification of numbers of G
(L and M) HeLa cells transfected with GFP-PI5P4K2A, 2B, 2C, and RFP-LC3 for 3
and imaged on confocal microscope. Bar, 10 mm. Quantification of cells (percenta
from (J) is shown in (M); n = 200 cells (mean ± SEM). See also Figure S5.
Moet al., 2012), is PI(4)P in resting cells (Rameh et al., 1997; White-
ford et al., 1997). Thus, reductions of PI(5)P levels hardly affect
PI(4,5)P2.
The ability of PI(5)P to regulate autophagy in cells depleted of
PI(3)P suggests that PI(5)P may account for the previously enig-
matic concept of PI(3)P-independent, noncanonical autophagy.
While we cannot exclude that a small amount of cellular PI(3)P
may be generated via VPS34-independent routes, as sug-
gested recently (Devereaux et al., 2013; McAlpine et al., 2013;
Zhou et al., 2010), we consciously used acute depletion of
PI(3)P using Wm to reduce the likelihood of such minor path-
ways having overt effects (compared to using genetic ap-
proaches, which would be necessarily more chronic and would
allow redundant pathways to become more apparent). Indeed,
Wm completely ablated the presence of WIPI2 and DFCP1 ves-
icles in our experiments. Since these effects and the concomi-
tant ATG5-ATG12 conjugation and autophagosome formation
were completely rescued by elevating PI(5)P in Wm-treated
cells, we suggest that PI(5)P can account for the previously
mysterious phenomenon of PI(3)P-independent autophagy.
While this would be compatible with the similar binding of
PI(3)P and PI(5)P toWIPI proteins (Baskaran et al., 2012; Jeffries
et al., 2004), it is possible that the two lipids may have some
nonredundant properties in the autophagy context. Indeed,
this appeared to be the case, as we found PI(5)P (and its precur-
sor PI(3,5)P2) localized on nascent and mature autophago-
somes during glucose starvation, and this is highly dependent
on the activity of the type III PtdInsP 5-kinase PIKfyve. Further-
more, glucose-starvation-induced autophagy appeared to
be dependent on PI(5)P and not PI(3)P. The Wm resistance of
glucose-starvation-induced autophagy was seen in HeLa cells,
SKNSH cells, and MEFs. While we do not know why this is the
case, given that one would expect VPS34 to be activated by up-
stream kinases under these conditions, one may speculate that
it is not sufficient simply to activate the enzyme, but one also
needs the enzyme to be in the right place, and perhaps the
mechanism governing the correct localization of VPS34 to auto-
phagosome precursors may be inefficient in glucose-starved
cells.n
C3-II/tubulin ratio in HeLa cells pretreated with Wm (200 nM, 2 hr), then loaded
ing GFP-LC3 treated as in (A) and then shifted to starvation media (HBSS) or
n (A) and subjected to western blot analysis with anti-HA antibody to detect free
was checked for endogenous proteins in the same conditions using an anti-
3-II/tubulin ratio in HeLa cells transfected with control, PI5P4K2A, 2B, and 2C
).
ith anti-HA antibody in HeLa cells treated with control, PI5P4K2A, 2B, and 2C
for 2 hr (mean ± SEM).
d 2C siRNA, were pretreated with Wm for 2 hr in complete medium and then
yc-tagged empty vector, myc-MTMR3WT, and myc-MTMR3C413S, incubated
. Cells were fixed, stained with anti-myc antibodies, and imaged by confocal
FP-LC3 vesicles per cell is shown in (K) (mean ± SEM).
0 hr were loaded with 10 mM PI(3)P for 1 hr in complete medium, and then fixed
ge of total) showing more than 10 RFP-LC3 vesicles in the different conditions
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Our observations may have therapeutic potential, because
PIKfyve and PI5P4K2 enzymes are drug-treatable targets (Davis
et al., 2013; Jefferies et al., 2008), and our data indicate that
suppression of PI5P4K2’s activity increased the clearance of
disease-associated autophagic substrates. Autophagy induc-
tion via other signaling effectors has benefits in a wide range of
neurodegenerative diseases caused by aggregate-prone intra-
cytoplasmic proteins, like Huntington’s and Parkinson’s dis-
eases (Harris and Rubinsztein, 2011). Thus, PI5P4K2’s inhibition
may provide a tractable therapeutic target for neurodegenerative
diseases.
EXPERIMENTAL PROCEDURES
Addition of Exogenous Lipids to Cells
Unlabeled PI, PI(5)P, PI(3)P, and PI (4)P di-C16; BODIPY-labeled PI(5)P and
PI(3)P di-C6; and carrier (Echelon) were reconstituted in H2O:tert-BuOH (9:1)
solution. After 1 min bath sonication, carrier and lipids were combined at a
1:1 ratio for 10 min at room temperature. The mixture of lipids and carrier
was diluted inmedia and used for 1–2 hr incubations on cells. The final concen-
trations used were 0.1-1-10 mM. For the negative control; DMEM was com-
bined with carrier only and added to the cells.
Lipid Beads Pull-Down Assay
HeLa cells (stably expressing GFP alone or GFP-WIPI2B or transiently ex-
pressing WIPI2D) were suspended in lipid-binding buffer (20 mM Tris-HCl,
150 mM NaCl, and 1 mM EDTA [pH 7.5]). The cells were passed ten times
through a G25 needle and sonicated on ice. After insoluble debris was
removed by high-speed centrifugation at 13,000 3 g for 1 hr at 4C, a 50 ml
slurry of PI, PI(3)P, PI(5)P, or unbound beads (Echelon Bioscience) was added
to the tube and incubated for 4 hr at 4C under rotary agitation. The beads
were washed five times with lipid-wash buffer (10 mM HEPES [pH 7.4],
150 mM NaCl, 0.25% NP40), and the bound proteins were subjected to
immunoblotting. For competitive inhibition with liposomes, cell extracts
were incubated on ice with 50 mM PS/PI(5)P, PS/PI(3)P liposomes for 3 hr
before the addition of PI(5)P or PI(3)P beads. Preincubation of the cell lysates
with liposomes containing only PS was used as a control with the same nega-
tive net charge.
SR-SIM
Samples were processed for conventional fluorescence microscopy and
mounted on high-precision size 1.5 coverslips (Carl Zeiss). Coverslips were
mounted with ProLong Gold antifade medium (P36934, Life Technologies),
which was left to cure for 3 days at room temperature to produce samples
with a consistent refractive index. SR-SIM was performed using an Elyra
PS1 instrument (Carl Zeiss). Samples were examined on the microscope using
a 633 1.4NA plan-apo Carl Zeiss objective lens and Immersol 518F (23C) im-
mersion oil. Image acquisition was carried out using ZEN 2012 Elyra edition
software, in which data sets were collected with five grating phases, five rota-Figure 6. PI(5)P Recruits Proteins Required for the Initiation of Autoph
(A) HeLa cells transfected with GFP-WIPI2B or GFP-DFCP1 preloaded with ind
incubated withWm in HBSSwere tracked by time-lapsemicroscopy for 10min aft
of those at the starting time [T0]) during the treatments are shown in the graphs.
(B–D) HeLa cells treated with control, PI5P4K2A, 2B, and 2C siRNAwere transfect
(1 hr); and then incubated with Wm in HBSS. WIPI2 or DFCP1 structures were tr
(E) Lysates from HeLa cells stably expressing GFP-WIPI2B were incubated with a
buffer, and recovered proteins were assessed by western blotting using antibodie
GFP alone were used as internal controls.
(F–H) Cell extracts from HeLa cells stably expressing GFP-WIPI2B were incuba
liposomes (G and H) before a pull-down experiment using the indicated beads.
assays in (F and G).
(I) Lysates from HeLa cells stably expressing GFP-WIPI2BWT and GFP-WIPI2B F
eluted with SDS-PAGE sample buffer, and recovered proteins were assessed by
Motions, and sufficient z positions spaced 110 nm apart to form an approximately
2 mm deep volume of raw SR-SIM data. Optimal grating frequencies were
selected for each wavelength used. Structured illumination postprocessing
was performed in ZEN using parameters determined by automated analysis
of the data sets. Reconstructed images were then corrected for spherical
and chromatic aberrations using channel alignment information, which was
created using a 3D array of multispectral beads previously imaged with the
same instrument settings. The average final image resolution was calculated
to be 110 nm in x and y dimensions and 240 nm in the z dimension, which rep-
resents a 2-fold lateral and axial improvement in resolution compared to con-
ventional microscopy. Final visualization and video production was performed
in Volocity 6.3 software using isosurface rendering of selected cropped re-
gions of the data sets.
Statistics
Protein levels were expressed as arbitrary units and numbers of vesicles or
aggregate formation were expressed as percentages from three independent
experiments carried out in triplicate, and the error bars denote SEM. Sig-
nificance levels for comparisons between two groups were determined
with two-tailed Student’s t test (Microsoft Excel); *p < 0.05; **p < 0.01;
***p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, one table, and twomovies and can be found with this article on-
line at http://dx.doi.org/10.1016/j.molcel.2014.12.007.
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icated concentrations of PI(5)P for 1 hr, starved in HBSS for 1 hr, and then
er the addition of Wm. Quantification of WIPI2B or DFCP1 vesicles (percentage
ed with GFP-WIPI2B (B), GFP-WIPI2D (C), or GFP-DFCP1 (D); starved in HBSS
acked and quantified as in (A).
garose beads coated with PI, PI(5)P, and PI(3)P, eluted with SDS-PAGE sample
s against GFP. Uncoated beads and lysates from HeLa cells stably expressing
ted for 3 hr with PI(5)P-containing liposomes (F and H) or PI(3)P-containing
PS-containing liposomes were used as internal controls for both competition
TTGmutant were incubated with agarose beads coated with PI(5)P and PI(3)P,
western blotting using antibodies against GFP. See also Figure S6.
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